Why TDOC rose 22.4% on Oct 29 2026: earnings beat
TDOC+22.4%on Thu Oct 29 2026
Teladoc Health, Inc. was up 22.4% on the day at $8.42, ranked #2 on 22.1× its usual five-minute volume, when TapeRank recorded this spike at 09:32 ET during regular hours.
THE DAY ON THE LIST · 1 EVENT
- 09:32 ETMOVER · REGULAR
$8.42 · ▲ 22.4% ON THE DAY · 22.1× 5M RVOL · RANK #2
JUSTIFIEDCONFIDENCE5/5Teladoc is up 12.9% pre-market after reporting a Q3 EPS and revenue beat, while raising the low end of full-year GAAP EPS guidance and narrowing its sales outlook. The move is supported by a concrete earnings catalyst, although the unchanged Q4 sales midpoint and still-negative outlook limit its strength.
WHYA 12.9% pre-market gain is broadly in line with a quarterly earnings beat and modest guidance improvement, rather than clearly excessive relative to the news.ANALYZED 09:14 ET · 17 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 09:32 ET
LAST8.42DAY▲ 22.4%5 MIN▲ 7.56%5M RVOL22.1×5M $VOL$6.7MFLOAT*181.7MRANK#2SESSIONREGULARVWAP7.98HOD8.50LOD7.40OR HIGH8.50OR LOW7.90PREV CLOSE6.88PM HIGH7.95PM LOW7.40GAP▲ 15.12%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $7.92, +15.1% on the previous close of $6.88
- 09:30 ETRegular-session low, $7.90
- 09:46 ETRegular-session high, $8.99
- 15:59 ETLast trade of the regular session, $8.72, +26.7% on the previous close of $6.88
- Volume: 18.5M shares in regular hours, 385K before the open
TDOC opened at $7.92 after the previous close of $6.88, briefly touched $7.90, then climbed to a session high of $8.99 at 09:46 ET. TapeRank read the move as justified by Teladoc’s quarterly earnings beat, which included stronger-than-expected EPS and revenue, a higher low end of full-year GAAP EPS guidance, and a narrower sales outlook. The stock finished the regular session at $8.72, up 26.7% from the previous close, with no halts during the session.
WRITTEN THU OCT 29 2026 16:01 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 08:57 ETStifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5Benzinga
- 06:38 ETNeedham Reiterates Hold on Teladoc Healthto HoldBenzinga
- WED 16:11 ETTeladoc Health Q3 EPS $(0.15) Beats $(0.21) Estimate, Sales $605.102M Beat $588.477M EstimateBenzinga
- WED 16:07 ETTeladoc Health Sees Q4 GAAP EPS $(0.23)-$(0.03) vs $(0.11) Est; Sees Sales $569.000M-$615.000M vs $597.389M EstBenzinga
- WED 16:07 ETTeladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B EstBenzinga
- WED 16:04 ET8-K — Results of Operations and Financial Condition; Financial Statements and ExhibitsSEC 8-K
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list